Toyobo and Human Metabolome Technologies (HMT) develop enzyme kit for depression biomarker

Research by HMT and others has revealed that the concentration of ethanolamine phosphate (PEA) in blood fluctuates according to the medical condition of depression, suggesting its utility as a biomarker to support depression diagnosis. HMT has developed an enzyme kit for PEA detection, and Toyobo will provide suitable enzymes such as ethanolamine phosphate lyase.

Toyobo news release, October 20, 2017

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny